Calibrate review: is it worth it?

Calibrate is not a drug; it is a "Metabolic Reset" coaching program built around a GLP-1 prescription. A clinician reviews your intake and lab work and, when medically appropriate, prescribes a GLP-1 receptor agonist (such as semaglutide/Wegovy or tirzepatide/Zepbound). These medications mimic gut hormones that slow stomach emptying, reduce appetite, and quiet food cravings, so you tend to eat less. On top of the medication, Calibrate layers an app-based curriculum and a coach you meet roughly every two weeks via video, targeting four pillars: food, sleep, exercise, and emotional health. The intent is that the drug curbs hunger while the coaching builds habits meant to help sustain weight loss; durable results after stopping the medication are not guaranteed.

Active ingredient: Brand-name GLP-1

Calibrate's own outcomes reports describe average weight loss of about 16% of body weight at one year (N=37,031), rising to roughly 18% at year two (N=11,132), 20% at year three (N=2,461), and 21% at year four (N=620), with metabolic gains such as about 80% of members who started with diabetes or prediabetes reaching normal HbA1c within a year. Important caveat: these are company-reported, retrospective figures from Calibrate's internal database (its 2026 Results Report and conference presentations), not results from an independent peer-reviewed randomized controlled trial, and the shrinking sample sizes in later years reflect members who stayed enrolled (survivorship bias). The robust peer-reviewed evidence sits with the underlying medications: in the NEJM-published STEP 1 trial, semaglutide 2.4 mg produced about 14.9% average weight loss versus 2.4% for placebo over 68 weeks, and in the head-to-head SURMOUNT-5 trial tirzepatide produced about 20.2% versus semaglutide's 13.7% at 72 weeks. Calibrate's results are broadly consistent with those drug trials plus coaching, but should be read as program marketing data, not independent proof.

Calibrate combines real FDA-approved GLP-1 medications with coaching and a behavior-change curriculum, and reports strong average results (about 16% at one year). The catch: those figures are company-reported, not from a peer-reviewed randomized trial, and the $199/month coaching fee stacks on top of medication and lab costs billed through your insurance. Best for people who value structured support and can get their GLP-1 covered. Confirm coverage in writing before committing, and treat any results claim as a marketing figure rather than a guarantee.